Estrella Immunopharma logo

Estrella Immunopharma Share Price (NASDAQ: ESLA)

$1.05

0.09

(9.38%)

Last updated on

Check the interactive Estrella Immunopharma Stock chart to analyse performance

Estrella Immunopharma stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.00
    Today's High:$1.07

    Day's Volatility :6.54%

  • 52 Weeks Low:$0.63
    52 Weeks High:$1.78

    52 Weeks Volatility :64.61%

Estrella Immunopharma Stock Returns

PeriodEstrella Immunopharma IncIndex (Russel 2000)
3 Months
6.19%
0.0%
6 Months
4.04%
0.0%
1 Year
-6.36%
0.0%
3 Years
-70.32%
-4.7%

Estrella Immunopharma Inc Key Stats

Check Estrella Immunopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.96
Open
$1.0
Today's High
$1.07
Today's Low
$1.0
Market Capitalization
$35.6M
Today's Volume
$62.4K
52 Week High
$1.78
52 Week Low
$0.63
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.24
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-268.5%

Stock Returns calculator for Estrella Immunopharma Stock including INR - Dollar returns

The Estrella Immunopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Estrella Immunopharma investment value today

Current value as on today

₹1,00,739

Returns

₹739

(+0.74%)

Returns from Estrella Immunopharma Stock

₹4,545 (-4.55%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Estrella Immunopharma Stock

-70%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Estrella Immunopharma Stock from India on INDmoney has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Estrella Immunopharma Stock

Rating
Trend

Estrella Immunopharma Share Price Target

What analysts predicted

Upside of 1423.81%

Target:

$16.00

Current:

$1.05

Estrella Immunopharma share price target is $16.00, a slight Upside of 1423.81% compared to current price of $1.05 as per analysts' prediction.

Estrella Immunopharma Stock Insights

  • Price Movement

    In the last 7 days, ESLA stock has moved up by 6.2%
  • ESLA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 88.2%

Estrella Immunopharma Technicals Summary

Sell

Neutral

Buy

Estrella Immunopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Estrella Immunopharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Estrella Immunopharma Inc logo
22.62%
4.04%
-6.36%
-70.32%
-70.32%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Estrella Immunopharma Inc

Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.
Organization
Estrella Immunopharma
Employees
0
CEO
Dr. Cheng Liu Ph.D.
Industry
Miscellaneous

Key Management of Estrella Immunopharma Inc

NameTitle
Dr. Cheng Liu Ph.D.
CEO, President & Director
Mr. Jiandong Xu
Chief Financial Officer

Important FAQs about investing in ESLA Stock from India :

What is Estrella Immunopharma share price today?

Estrella Immunopharma share price today is $1.05 as on at the close of the market. Estrella Immunopharma share today touched a day high of $1.07 and a low of $1.00.

What is the 52 week high and 52 week low for Estrella Immunopharma share?

Estrella Immunopharma share touched a 52 week high of $1.78 and a 52 week low of $0.63. Estrella Immunopharma stock price today i.e. is closed at $1.05, lower by 41.01% versus the 52 week high.

How to invest in Estrella Immunopharma Stock (ESLA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Estrella Immunopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Estrella Immunopharma Shares that will get you 1.4286 shares as per Estrella Immunopharma share price of $1.05 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Estrella Immunopharma Stock (ESLA) from India?

Indian investors can start investing in Estrella Immunopharma (ESLA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Estrella Immunopharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Estrella Immunopharma share’s latest price of $1.05 as on August 30, 2025 at 1:29 am IST, you will get 9.5238 shares of Estrella Immunopharma. Learn more about fractional shares .

What are the returns that Estrella Immunopharma has given to Indian investors in the last 5 years?

Estrella Immunopharma stock has given -70.32% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?